Octeris

Octeris is a medical technology company and a subsidiary of PAVmed, focused on the development and commercialization of advanced endoscopic imaging solutions. The company was formed in 2026 to advance a multi-modality endoscopic esophageal imaging technology licensed from Duke University. This technology is specifically designed to identify and facilitate the treatment of esophageal dysplasia during upper endoscopy procedures, addressing a critical need in gastrointestinal diagnostics. Octeris operates under the leadership of Joseph Virgilio and supports ongoing sponsored research at Duke University to transition its licensed assets toward clinical application. As part of PAVmed's broader medical device portfolio, Octeris aims to leverage innovative imaging to improve patient outcomes in esophageal health.